Abstract
All the patients (73) in the Rheumatology Department five year study of second line therapy who have taken hydroxychloroquine (Plaquenil) for rheumatoid arthritis for longer than 18 months were reviewed. These patients have their treatment dosage carefully monitored and have been receiving regular ophthalmic examinations. Most patients still taking the drug were assessed with a battery of tests for evidence of retinal toxicity. No retinal toxicity causing visual loss was found.
On the basis of these results and a review of the recent literature we no longer routinely screen patients for hydroxychloroquine retinal toxicity in Cardiff.
Similar content being viewed by others
Article PDF
References
Adams EM, Yocum DE, Bell CL : Hydroxychloroquine in the treatment of rheumatoid arthritis. Am J Med 1983, 75: 321–6.
Marks JS : Chloroquine retinopathy; is there a safe daily dose? Ann Rheum Dis 1982, 41: 52–8.
Shearer RV, Dubois EL : Ocular changes induced by long term hydroxychloroquine therapy. Am J Ophthalmol 1967, 64: 245–52.
Adlakha D, Crews SJ, Shearer ACI, Tonks EL : Electrodiagnosis in drug induced disorders of the eye. Trans Ophthalmol Soc UK 1967, 89: 267–84.
Mackenzie AH : Dose refinements in long term therapy of rheumatoid arthritis with antimalarials. Am J Med 1983, (Supp): 40–45.
Mikkelsen J : Ocular complications of treatment with antimalarial drugs in dermatology. Ugeskr Laeg 1979,141: 2316–18.
Rynes RI : Ophthalmologic safety of long term hydroxychloroquine sulfate treatment. Am J Med 1983, Supp: 35–39.
Finbloom DS, Silver K, Newsome DA, Gunkel R : Comparison of Hydroxychloroquine and chloroquine use and the development of retinal toxicity. J Rheumatol 1985; 12: 692–4.
Mantyjarvi M : Hydroxychloroquine treatment and the eye. Scand J Rheumatol 1985; 14: 171–4.
Johnson MW, Vine AK : Hydroxychloroquine therapy in massive doses without retinal toxicity. Am J Ophthalmol 1987, 104: 139–44.
Bernstein HN : Ophthalmologic considerations and testing in patients receiving long term antimalarial therapy. Am J Med 1983, Supp: 25–34.
Walker G : ABPI Data Sheet compendium 1988-89; London, Datapharm, 1989; 1516.
Fleck BW, Bell AL, Mitchell JD, Thompson BJ, Hurst NP, Nuki G : Screening for antimalarial maculopathy in rheumatology clinics. Br Med J 1985, 291: 782–5.
Khaw KT : Screening: the need for a balance. Eye 1989, 3: (editorial).
Percival SPB and Meanock I : Chloroquine: ophthalmological safety and clinical assessment in rheumatoid arthritis. Br Med J 1968, 3: 579–84.
Scherbel AL, Mackenzie AH, Nousek JE, Atdjian M : Ocular lesions in rheumatoid arthritis and related disorders with particular reference to retinopathy. N Engl J Med 1965, 273: 360–6.
Friedmann AI : The early detection of chloroquine retinopathy with the Friedmann visual field analyser. Ophthalmologica 1969,158 (supp): 583–91.
Easterbrook M : The sensitivity of Amsler grid testing in early chloroquine retinopathy. Trans Ophthalmol Soc UK 1985, 104: 204–7.
Frenkel M : Safety of hydroxychloroquine (letter). Arch Ophthalmol 1982, 100: 841.
Spalton DJ : Chloroquine and the eye. Br J Clin Pract supp 52: 50–55.
Bishara SA and Matamoros N : Evaluation of several tests in screening for chloroquine maculopathy. Eye 1989, 3: 777–82.
Sassaman FW, Cassidy JT, Alpern M, Maaseidvaag F : Electro-retinography in patients with connective tissue disease treated with hydroxychloroquine. Am J Ophthalmol 1970, 70: 515–23.
Arden GB and Kolb H : Antimalarial therapy and early retinal changes in patients wtih rheumatoid arthritis. Br Med J 1966, 1: 270–83.
Mills PV, Beck M, Power BJ : Assessment of the retinal toxicity of hydroxychloroquine. Trans Ophthalmol Soc UK 1981, 101: 109–13.
Husain Z . and Runge LA : Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine and levamisole. J Rheumatol 1980, 7: 825–30.
Davis MJ and Dawes PT : Monitoring therapy in rheumatological practice. Br J Rheumatol 1990, 29 (Abst 1): 5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morsman, C., Livesey, S., Richards, I. et al. Screening for hydroxychloroquine retinal toxicity: Is it necessary?. Eye 4, 572–576 (1990). https://doi.org/10.1038/eye.1990.79
Issue Date:
DOI: https://doi.org/10.1038/eye.1990.79